AOD-9604: A Growth Hormone Fragment in Lipid Metabolism Research
AOD-9604 is a synthetic fragment of human growth hormone studied in vitro for its interactions with lipid metabolism and fat-cell signaling pathways. For laboratory research use only.
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH). Specifically, it corresponds to a modified fragment representing the portion of the growth hormone molecule associated with lipid-related activity. Because it captures this segment without the full hormone structure, AOD-9604 has become a focused research tool for investigators studying how growth hormone influences fat metabolism at the cellular level.
This article reviews the documented laboratory research directions associated with AOD-9604. The content is educational and describes in-vitro and preclinical investigation only. AOD-9604 is a research compound and is not intended for human or animal use.
Overview
Growth hormone is known to affect a wide range of physiological processes, including how the body handles lipids. Researchers have long been interested in isolating the specific structural regions of the hormone responsible for particular activities. AOD-9604 emerged from this line of inquiry as a fragment modeling the lipolytic (fat-metabolizing) region of hGH.
By studying a defined fragment rather than the entire hormone, laboratories can probe metabolic signaling pathways with greater specificity. AOD-9604 is therefore examined as a tool for understanding the mechanisms by which growth hormone-related signaling engages adipose tissue and lipid handling in controlled experimental systems.
Mechanism of Action
AOD-9604 is studied for its association with lipid metabolism in fat cells, or adipocytes. In cell-based research, the fragment is examined for its potential to influence the processes of lipolysis, the breakdown of stored lipids, and lipogenesis, the formation of new lipid stores. The prevailing research interest is in how the peptide may modulate the balance between these opposing pathways.
Unlike full-length growth hormone, AOD-9604 is generally reported in laboratory studies to interact with lipid-related signaling without strongly engaging the pathways associated with growth or glucose regulation. This selective profile is one reason the fragment is of interest as a research probe. Investigators study the intracellular signaling events, enzyme activity, and gene-expression changes associated with the peptide in adipocyte models. As with any research peptide, the precise molecular details are refined through empirical laboratory work rather than assumed.
Primary Research Areas
Laboratories investigating AOD-9604 have concentrated on several themes:
These focus areas reflect the questions most commonly explored when characterizing AOD-9604 as a metabolic research tool.
What Preclinical Studies Explore
Preclinical and in-vitro studies involving AOD-9604 typically explore how the fragment behaves in defined cellular models of adipose tissue. Researchers measure changes in lipid metabolism markers, assess enzyme activity involved in fat breakdown and storage, and observe cellular responses across a range of experimental conditions. Work in model systems has examined the peptide's association with lipid mobilization without the broader effects attributed to complete growth hormone signaling.
Studies of this nature are designed to clarify mechanisms within controlled laboratory settings. They contribute to the scientific understanding of growth hormone fragment biology but do not establish clinical outcomes. Results obtained in cell or tissue models cannot be extrapolated to living organisms or human application.
Handling in the Lab
AOD-9604 is generally supplied as a lyophilized powder, which supports stability during storage and transit. Good-practice laboratory handling includes reconstitution with an appropriate sterile diluent such as bacteriostatic water, gentle mixing to dissolve the peptide, and avoidance of repeated freeze-thaw cycles that can compromise peptide integrity.
The lyophilized form is typically stored frozen and protected from light and moisture. Reconstituted solutions are usually refrigerated and used within a limited period consistent with the laboratory's stability data. Researchers should adhere to their institution's standard operating procedures and consult the certificate of analysis for compound-specific recommendations.
Research Context
AOD-9604 represents a useful example of how a defined hormone fragment can serve as a targeted research tool. By isolating the lipid-associated region of growth hormone, the peptide allows investigators to study fat metabolism signaling with a specificity that the full hormone does not readily permit. It remains a subject of ongoing laboratory interest within metabolic research.
All information here reflects documented research directions rather than established therapeutic applications. AOD-9604 is intended strictly for in-vitro laboratory research and is not approved for human or veterinary use.
Research Use Only
This article is provided for informational and educational purposes only. All products referenced are intended strictly for in-vitro research use and are not for human or animal consumption. These statements have not been evaluated by the FDA.
